Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
rabeprazole sodium, Quantity: 10 mg
Arrotex Pharmaceuticals Pty Ltd
Rabeprazole sodium
Tablet, enteric coated
Excipient Ingredients: povidone; mannitol; sodium starch glycollate type A; diethyl phthalate; purified talc; magnesium stearate; hypromellose phthalate; light magnesium oxide; iron oxide red; titanium dioxide; ethylcellulose
Oral
28
(S4) Prescription Only Medicine
Rabeprazole is indicated for: - Treatment and prevention of relapse of gastro-oesophageal reflux disease. - Symptomatic treatment of gastro-oesophageal reflux disease. - Treatment of duodenal ulcers. - Treatment of gastric ulcers. Patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (NSAIDs) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. Rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: - Eradication of Helicobacter pylori in patients with peptic ulcer disease or chronic gastritis. - Healing of peptic ulcers in patients with Helicobacter pylori associated ulcers.
Visual Identification: Pink coloured, round, biconvex, delayed release tablet, plain on both sides.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2016-01-06
CHEMMART RABEPRAZOLE TABLETS _Rabeprazole sodium_ CONSUMER MEDICINE INFORMATION _FOR A COPY OF A LARGE PRINT LEAFLET, PH: 1800 195 055_ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about rabeprazole. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again. WHAT THIS MEDICINE IS USED FOR Rabeprazole is used to treat reflux oesophagitis, peptic ulcers and chronic gastritis. It belongs to a group of medicines called proton pump inhibitors (PPIs). REFLUX OESOPHAGITIS This can be caused by food and acid from the stomach flowing the wrong way (reflux) back up the food pipe (oesophagus). Reflux can cause a burning sensation in the chest rising up to the throat (heartburn). Rabeprazole also helps to stop reflux oesophagitis from coming back. PEPTIC ULCERS This can be caused by the stomach making too much acid. It is called a gastric (stomach) or duodenal ulcer depending on the position of the ulcer. People who have a peptic ulcer may also have bacteria called Helicobacter pylori in their stomach. Taking antibiotics will kill Helicobacter pylori and allow the ulcer to heal. CHRONIC GASTRITIS Helicobacter pylori may inflame the stomach, resulting in pain, nausea and vomiting. Taking antibiotics will kill Helicobacter pylori and allow the stomach to heal. _HOW IT WORKS_ Rabeprazole works by decreasing the amount of acid the stomach makes, to give relief from the symptoms and allow healing to take place. Your food is still digested in the same way. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed this medicine for another reason. This medicine is not addictive. The Lue koko asiakirja
1 AUSTRALIAN PRODUCT INFORMATION CHEMMART RABEPRAZOLE (RABEPRAZOLE SODIUM) ENTERIC COATED TABLETS 1 NAME OF THE MEDICINE Rabeprazole sodium 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each enteric coated (EC) tablet contains 10 mg rabeprazole sodium (equivalent to 9.42 mg rabeprazole) or 20 mg rabeprazole sodium (equivalent to 18.85 mg rabeprazole), as the active ingredient For the full list of excipients see section 6.1 LIST OF EXCIPIENTS 3 PHARMACEUTICAL FORM CHEMMART RABEPRAZOLE ENTERIC COATED TABLETS 10 MG ENTERIC COATED TABLETS: Pink coloured, round, biconvex tablets, plain on both sides. 20 MG ENTERIC COATED TABLETS: Yellow coloured, round, biconvex, plain on both sides. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Rabeprazole EC tablet is indicated for: • Treatment and prevention of relapse of gastro-oesophageal reflux disease • Symptomatic treatment of gastro-oesophageal reflux disease • Treatment of duodenal ulcers • Treatment of gastric ulcers. Patients whose gastric and duodenal ulceration is not associated with ingestion of non- steroidal anti-inflammatory drugs (NSAIDs) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. Rabeprazole EC tablet is also indicated, in combination with clarithromycin and amoxycillin, for: • Eradication of _ Helicobacter pylori_ in patients with peptic ulcer disease or chronic gastritis • Healing of peptic ulcers in patients with _Helicobacter pylori_ associated ulcers. 2 4.2 DOSE AND METHOD OF ADMINISTRATION CHEMMART Rabeprazole enteric-coated tablets are intended for oral administration. DOSAGE Rabeprazole EC tablets should not be chewed or crushed, but should be swallowed whole and should be taken at the same time each day to facilitate treatment compliance. Rabeprazole was taken with or without food in the pivotal clinical trials. ADULTS _Treatment of active Gastro-Oesophageal Reflux Disease (GORD_): The recommended oral dose for this condition is one 20 mg tablet to be Lue koko asiakirja